Amylyx Pharmaceuticals (AMLX) Earnings Date & Reports

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AMLX is expected to report earnings to rise 12.73% to -62 cents per share on May 08

Amylyx Pharmaceuticals AMLX Stock Earnings Reports

Q1'25

Est.

$-0.62

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.37

Q2'24

Missed

by $0.34

Q1'24

Missed

by $1.74

The last earnings report on March 04 showed earnings per share of -55 cents, beating the estimate of -56 cents. With 721.36K shares outstanding, the current market capitalization sits at 310.99M.

View a ticker or compare two or three

Compare

AMLX